In Patients with Cardiogenic Shock, Extracorporeal Membrane Oxygenation Is Associated with Very High All-Cause...

Area of Science:

• Cardiology
• Critical Care Medicine
• Medical Devices

Background:

• Cardiogenic shock is a life-threatening condition requiring advanced circulatory support.
• Extracorporeal membrane oxygenation (ECMO) is an option for severe cases, but its impact on mortality requires careful evaluation.
• Exclusion of other mechanical support devices like Impella and Intra-aortic Balloon Pump (IABP) is crucial for isolating ECMO's effect.

Purpose of the Study:

• To assess the association between ECMO use and in-hospital mortality in adult patients diagnosed with cardiogenic shock.
• To analyze mortality rates in cardiogenic shock patients treated with ECMO, specifically excluding Impella and IABP.
• To identify potential complications associated with ECMO in this patient population.

Main Methods:

• Utilized the Nationwide Inpatient Sample (NIS) database from 2016-2020.
• Identified adult patients (≥18 years) with cardiogenic shock using ICD-10 codes.
• Compared mortality and complication rates between patients treated with ECMO (without IABP) and those without mechanical support.

Main Results:

• A total of 796,585 patients had cardiogenic shock; 13,160 received ECMO without IABP.
• In-hospital mortality was 32.7% without support and 47.9% with ECMO.
• Multivariate analysis, adjusting for 47 variables, showed ECMO significantly increased mortality risk (OR: 1.78, CI: 1.6-1.9, p < 0.001).
• Similar findings were observed in teaching hospitals, with high rates of major complications in the ECMO cohort.

Conclusions:

• ECMO use in cardiogenic shock patients is linked to increased in-hospital mortality.
• This association persists irrespective of patient comorbidities, high-risk factors, or hospital type.
• Further research may be needed to optimize ECMO strategies for cardiogenic shock.